ULTRESA
Dead / Abandoned — Abandoned — failure to respond (as of 22 Feb 2011)
What this means for you
This application is over — abandoned 27 Dec 2010. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77769225
- Mark type
- Stylized text
- Filed
- 26 Jun 2009
- Abandoned
- 27 Dec 2010
- Attorney of record
- Abigail Rubinstein and Paul Fields
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pancreatic and gastrointestinal diseases and disorders
Owner
- AXCAN PHARMA US, INC., Bridgewater, NJ, US
Prosecution history
- 23 Feb 2011 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 22 Feb 2011 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 27 Jun 2010 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 27 Jun 2010 — INQUIRY TO SUSPENSION E-MAILED
- 27 Jun 2010 — SUSPENSION INQUIRY WRITTEN
- 14 May 2010 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 13 May 2010 — ASSIGNED TO LIE
- 06 Nov 2009 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 06 Nov 2009 — LETTER OF SUSPENSION E-MAILED
- 06 Nov 2009 — SUSPENSION LETTER WRITTEN
- 22 Oct 2009 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Oct 2009 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Oct 2009 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Sept 2009 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Sept 2009 — NON-FINAL ACTION E-MAILED